A detailed history of Redwood Investments, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Redwood Investments, LLC holds 118,086 shares of ALKS stock, worth $2.87 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
118,086
Previous 115,979 1.82%
Holding current value
$2.87 Million
Previous $3.22 Million 0.65%
% of portfolio
0.84%
Previous 0.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$26.4 - $32.56 $55,624 - $68,603
2,107 Added 1.82%
118,086 $3.2 Million
Q4 2023

Jan 19, 2024

SELL
$23.37 - $28.68 $7.47 Million - $9.17 Million
-319,609 Reduced 73.37%
115,979 $3.22 Million
Q3 2023

Oct 24, 2023

BUY
$27.17 - $31.97 $11.8 Million - $13.9 Million
435,588 New
435,588 $12.2 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $3.99B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.